Study to compare the safety and efficacy of 2 different doses of inhaled D8-THC to standard therapy with ondansetron in the prevention of acute nausea from moderately emetogenic chemotherapy.
Latest Information Update: 28 Dec 2020
At a glance
- Drugs Delta-8-THC (Primary) ; Ondansetron
- Indications Nausea
- Focus Therapeutic Use
- Sponsors Rafa Laboratories
- 20 Dec 2020 Status changed from suspended to discontinued.
- 09 Sep 2006 New trial record.